.

Professor Jonathan M. Gibson MB BS, MD, FRCS(Ed), FRCOphth

Jonathan Gibson

Professor of Ophthalmology

School of Life and Health Sciences
Aston University
Birmingham B4 7ET
UK

Consultant Ophthalmologist,
Heart of England NHS Foundation Trust
Honorary Senior Lecturer, University of Birmingham Medical School

E mail: j.m.gibson@aston.ac.uk

Telephone +44 (0) 121 204 3800

Co-ordinator of clinical teaching in ophthalmology, Undergraduate Optometry Programme

Member of the Ophthalmic Research Group

Member of research strand: 'Ageing lives: the social, psychological and public policy contexts of health behaviour and medicines management' -  Aston Research Centre for Healthy Ageing 

Career History

  • 1971-1976: Medical College of St.Bartholomew’s Hospital, University of London.
  • 1977-1978: Pre-registration house jobs in London and Edinburgh.
  • 1978-1981: Senior House Office and Registrar in Ophthalmology, Princess Alexandra Eye Pavilion, Royal Infirmary Edinburgh.
  • 1981-1986: Lecturer/Hon.Senior Registrar in Ophthalmology, University of Leicester and Leicester Royal Infirmary
  • 1986-2011: Consultant Ophthalmic Surgeon, Birmingham and Midland Eye Centre, Sandwell & West Birmingham NHS Trust.
  • 1986-current: Consultant Ophthalmologist Birmingham Heartlands and Solihull Hospitals, Heart of England Foundation Trust
  • 1990-current: Honorary Senior Lecturer, University of Birmingham Medical School
  • 2007-current: Personal Chair in Ophthalmology, Aston University

Qualifications

  • 1976 Bachelor of Medicine, Bachelor of Surgery,  St Bartholomew's Hospital, University of London
  • 1981 Fellow of the Royal College of Surgeons, Edinburgh
  • 1987 MD University of Leicester

  • 1989 Fellow of the Royal College of Ophthalmologists

Awards

  • 2005-current: Silver (Level 10) Clinical Excellence Award

  • 2009-2010: Macular Disease Society – Joint Inaugural Winner best clinical service (BMEC)

Teaching responsibilities

Third Year Undergraduate

  • Hospital Ophthalmology Clinical Teaching

  • Diabetic Retinopathy Screening Module

  • Aston Ophthalmology Referral Clinic (with Dr. Doina Gherghel)

Ophthalmic Doctorate

  • Retina and Macula Module (With Dr. Hannah Bartlett)

Current Research Interests

  • Imaging of the human fundus – collaboration: Dr. Antonio Calcagni, Professor Ela Claridge, Dr.Iain Styles, University of Birmingham.

  • Age related macular degeneration

  • Diabetic retinopathy – collaboration Professor Paul Dodson, Heart of England NHS Foundation Trust;

  • Retinal vascular disorders

  • European Vision Institute Clinical Trials Network -; Collaborator Prof. Jose Cunha Vaz, Coimbra, Portugal.

  • Enhanced Vision Programme -: Collaboration Professor Yit Yang Wolverhampton, Professor Victor Chong Oxford, Dr.Jennifer Acton ,Columbia University, New York.

Professional Offices

  • 1997-2003: Member of Council, The Royal College of Ophthalmologists, London

  • 2001-2002: Director of Research and Development, Heartlands Solihull NHS Trust

  • 2001-2002: Past President Midland Ophthalmological Society

  • 1995-2001: Regional Adviser in Ophthalmology, Royal College Surgeons, Edinburgh.

  • 1993-2009: Examiner in Ophthalmology, Royal College Surgeons, Edinburgh

  • 1991- current: Examiner for Royal College of Ophthalmologists

  • 2003-2006: Chairman Solihull Division, British Medical Association.

  • 2005-2008: College Tutor, Royal College of Ophthalmologists

  • 1997-2004: Overseas examiner, FRCSEd Ophthalmology Saudi Arabia and India and Bahrein.

  • 2010-current: Co- Chair Birmingham and Black Country CLRN Research Network Ophthalmology and Vision Science

Publications and Presentations

Author of 93 research and clinical papers, 1 textbook and 5 book chapters

Textbook

CLINICAL RETINOPATHIES. Dodson, Gibson, Kritzinger. Chapman & Hall Publishers, London, November 1994

Book Chapters

S.M.Eames, J.M.Gibson and J.N.West : Hypertensive Retinopathy. In C-E Mogensen ed. Target Organ Damage in the Mature Hypertensive ,London, Science Press Ltd 1993, 1.11-1.20.

J.M.Gibson: Diabetic retinopathy; Diabetic maculopathy. In Key Topics in Ophthalmology. BIOS  Scientific Publishers Ltd, London 1995 ;  89-99.

J.M.Gibson: Diabetic retinopathy; Diabetic maculopathy. In Key Topics in Ophthalmology, BIOS Scientific Publishers, London, 2001.

J.M.Gibson:”Other ophthalmic lesions in the fundus”. In Diabetic Retinopathy, Oxford Diabetes Library, Oxford University Press, 2008.

J.M.Gibson; “Ophthalmic treatment of diabetic retinopathy”, in Diabetic Retinopathy, Oxford Diabetes Library, Oxford University Press, 2008

Publications since 2001

  • Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY. Age-related macular degeneration is assopciated with increased vascular endothelial growth factor, haemorheology and endothelial dysfunction. Ophthalmology 2001; 108:705-710.
  • Gibson JM. .Editorial : Confocal scanning laser Doppler flowmetry in retinovascular disease Eye 2001; 15:259-260.
  • Cheung CM, Kumar V, Saeed T, Gibson JM, Murray PI. Acute annular outer retinopathy. Arch Ophthalmol 2002; 120: 993.
  • Denniston A, Banerjee S, Gibson JM, Dodson P. Does cardiovascular therapy affect the recurrence of preretinal and vitreous haemorrhage in diabetic eye disease? Clin Exp Ophthalmol 2002;30(suppl):A 390
  • Banerjee S, Denniston A, Gibson JM, Dodson P. Do cardiovascular therapies affect onset of preretinal and vitreous haemorrhages in diabetic patients? Clin Exp Ophthalmol 2002; 30(suppl):A 389.
  • Chaterjee S, Gibson JM. Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 2003;87:925-27
  • Harding S, Greenwood R, Aldington S, Gibson J, Qwens D, Taylor R, Kohner E, Scanlon P, Leese G.; Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003; 20: 965-71
  • S.Banerjee, AKO Denniston, JM Gibson, PM Dodson. Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrkage in diabetic eye disease? Eye 2004, 18:821-825.
  • Lip PL, Chaterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, Lip GY. Plasma endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol 2004, 88:1543-6
  • Al- Husainy SS, Farmer J, Gibson JM, Dodson PM. .Is measurement of blood pressure worthwhile in the diabetic eye clinic? Eye, 2005, 19: 312-316.
  • Gibson J. Editorial: Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia. Eye 2005,18:829-830
  • Denniston AK, BanerjeeS, GibsonJM, Dodson PM. Cardiovascular therapies and their role in diabetic eye disease. Diabet Med 2005;22 : 665-6
  • analysis of multi-spectral fundus images. Med Image Annal 2006:10: 578-97.
  • Cubbidge RP, Hosking SL, Hilton EJ, Gibson JM. Regression analysis of ranked segment parameters for optic nerve head classification: a pilot study. Ophth Phys Opt 2007; 27: 194-200.
  • Al-Hussainy S, Dodson PM, Gibson JM. Pain Response and follow up of patientsundergoing panretinal laser photocoagulation with reduced exposure times. Eye 2008 22:96-99.
  • Gibson JM. Screening for eye disease in the elderly: is it worth it? Br J Hosp Med 2009; 70(10): 554 - 555.
  • Berrow EJ, Bartlett HE, Eperjesi F, Gibson JM The electroretinogram: a useful tool for evaluating age-related macular disease?  Doc Ophthalmol. 2010 Aug;121(1):51-62. Epub 2010 Mar 16. Review
  • Musadiq M, Gibson J. Spontaneous resolved macroaneurysm associated with a congenital anomalous retinal artery. Retinal cases and brief reports 2010; 4: 70-72
  • Bhatnagar AJ, GibsonJM, El-Sherbiny S. Spectral Domain Optical Coherence Tomography Can Detect Visible and Subthreshold Laser Burns Using 532-nm Laser. Ophthalmic Surg Lasers Imaging. 2010 Dec 1;41 Online:e1-3. doi: 10.3928/15428877-20101124-09.
  • Everdell NL, Styles IB, Calcagni A, Gibson J, Hebden J, Claridge E Multispectral imaging of the ocular fundus using light emitting diode illumination. Rev Sci Instrum. 2010 Sep;81(9):093706
  • Patel SR, Bellary S, Qin L, Gill PS, Taheri S, Heitmar R, Gibson JM, Gherghel D  Abnormal retinal vascular function and lipid levels in a sample of healthy UK South Asians. Br J Ophthalmol. 2011 Nov;95(11):1573-6. Epub 2011 Mar 1
  • Acton JH, Cubbidge RP, King H, Galsworthy P, Gibson JM. Drusen detection in retro-mode imaging by a scanning laser ophthalmoscope.Acta Ophthalmol. 2011 Aug;89(5):e404-11. doi: 10.1111/j.1755-3768.2011.02123.x. Epub 2011 Feb 18
  • Calcagni A, Gibson JM, Styles IB, Claridge E, Orihuela-Espina F Multispectral retinal image analysis: a novel non-invasive tool for retinal imaging. Eye (Lond). 2011 Sep 9. doi: 10.1038/eye.2011.202. [Epub ahead of print]

Completed Research Grants

  • 2003-2005: Co grant holder with Professor Ela Claridge, Birmingham University, of EPSRC Grant for £120k to investigate and develop and new means of fundus imaging interpretation.

  • 2003- 2008: Principal Investigator at BMEC, Cohort Study of Verteporfin -PDT laser in AMD. Sponsor ; NHS

  • 2004-2006: Principal Investigator Anecortave Acetate Trial in AMD

  • 2005-2007: Principal Investigator,EXCITE and SECURE studies in AMD , sponsor Novartis

  • 2008 – 2011: Principal Investigator , VIEW 2 Study of VEGF Trap in AMD, Aston University, Sponsor Bayer-Schwering..

  • 2009-2011: Principal Investigator  unrestricted educational grant £29,000 “Teleophthalmology Project”; sponsor Novartis.

Current Research Grants

  • 2008- current: Principal Investigator IVAN Trial at BMEC, sponsor MRC/NHS

  • 2009- 2012: Co- investigator Aston/Birmingham Retinal Imaging Group -  Dunhill Charity “multispectral imaging of the fundus”  awarded £98,000

  • 2011- current: Principal Investigator RET-2010 trial, at MIDRU HEFT NHS Trust, sponsor EVICR.Net

  • 2011-current: Principal Investigator RELIGHT Study of Lucentis in DMO, at MIDRU, HEFT NHS Trust.  Sponsor Novartis

  • 2011-current: Principal Investigator LUMINOUS Study, Sponsor Novartis.

  • 2011-current: Principal Investigator, EuroCondor Study by EVICR.Net, EU FP7 Grant for €330,000.

  • 2011-current: Collaborative study with Belfast – “assessment of preferential hyperacuity perimetry in monitoring of wet AMD Patients.” Unrestricted grant of £6,000 from Novartis.

Membership of Professional Bodies

  • Fellow Royal College of Ophthalmologists
  • Member British Medical Association
  • Fellow Royal College of Surgeons of Edinburgh
  • American Academy of Ophthalmology
  • Midland Ophthalmological Society
  • Medical Retina Group (Co-founder)
  • Fellow Royal Society of Medicine

Reviewer Experience

Reviewer for NIHR, Diabetes UK, British Journal of Ophthalmology, Eye, Clinical and Experimental Ophthalmology